ArticleERJ open research2021

Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis.

Evans R Fernández Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.